Here are four notes:
1. Newark, Calif.-based StemCells, a biotech company, is seeking 40 patients who have cervical spinal cord injuries causing full paralysis of the legs and at least partial paralysis of the arms.
2. StemCells is conducting a randomized, blinded trial to test whether stem cells restore function and sensation in patients.
3. The company said seven patients of 12 patients with thoracic spinal cord injuries experienced new sensations below the injury level in the middle of the back after receiving stem cell treatments.
4. A different Phase I trial found five patients of the six quadriplegia patients involved in the trial showed enhanced upper-body strength. Four of the six patients also developed better dexterity six months after treatment.
More articles on spine:
Drs. Andrew Manista, Jonathan Tuttle & more: 10 spine, neurosurgeons in the headlines this week
5 results from AMA survey on opioid abuse
Cooling provides insight into how brain produces speech — 7 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.